<bill session="117" type="hc" number="42" updated="2022-12-31T05:25:28Z">
  <state datetime="2021-07-21">REFERRED</state>
  <status>
    <introduced datetime="2021-07-21"/>
  </status>
  <introduced datetime="2021-07-21"/>
  <titles>
    <title type="official" as="introduced">Expressing the sense of Congress that governmental entities should use a portion of the proceeds from litigation against opioid manufacturers and distributors to increase participation in drug take back programs and for the safe disposal of collected, unused medicines.</title>
    <title type="display">Expressing the sense of Congress that governmental entities should use a portion of the proceeds from litigation against opioid manufacturers and distributors to increase participation in drug take back programs and for the safe disposal of collected, unused medicines.</title>
  </titles>
  <sponsor bioguide_id="M001180"/>
  <cosponsors>
    <cosponsor bioguide_id="C001119" joined="2021-10-19"/>
    <cosponsor bioguide_id="D000619" joined="2021-09-28"/>
    <cosponsor bioguide_id="D000631" joined="2021-08-06"/>
    <cosponsor bioguide_id="D000623" joined="2021-10-08"/>
    <cosponsor bioguide_id="D000615" joined="2021-10-19"/>
    <cosponsor bioguide_id="F000466" joined="2021-10-19"/>
    <cosponsor bioguide_id="G000597" joined="2021-10-19"/>
    <cosponsor bioguide_id="H001072" joined="2021-09-14"/>
    <cosponsor bioguide_id="K000391" joined="2021-09-14"/>
    <cosponsor bioguide_id="M000194" joined="2021-12-09"/>
    <cosponsor bioguide_id="M001215" joined="2021-08-06"/>
    <cosponsor bioguide_id="P000614" joined="2021-10-08"/>
    <cosponsor bioguide_id="R000395" joined="2021-10-26"/>
    <cosponsor bioguide_id="R000577" joined="2021-09-22"/>
    <cosponsor bioguide_id="T000480" joined="2021-08-03"/>
    <cosponsor bioguide_id="T000483" joined="2021-07-21"/>
    <cosponsor bioguide_id="W000795" joined="2021-10-05"/>
  </cosponsors>
  <actions>
    <action datetime="2021-07-21">
      <text>Introduced in House</text>
    </action>
    <action datetime="2021-07-21" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2021-07-22">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Civil actions and liability"/>
    <term name="Consumer affairs"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Prescription drugs"/>
    <term name="Solid waste and recycling"/>
    <term name="State and local finance"/>
    <term name="State and local government operations"/>
    <term name="Transportation costs"/>
  </subjects>
  <amendments/>
  <summary date="2021-09-10T18:41:37Z" status="Introduced in House">This concurrent resolution expresses the sense of Congress that government entities should consider using a portion of proceeds from litigation against opioid manufacturers and distributors for drug take-back programs.</summary>
</bill>
